Company / Net Income
Vericel Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$16.5M
FY2025
5-year range
-$9.7M / $16.5M
FY2021-FY2025
Trend
+59.4%
vs FY2024
Sector context
#56 of 216
Health Care
What the data says
At $17M, Vericel's net income ranks #56 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$20M in FY2016 to $17M in FY2025.
Based on SEC 10-K filings.
$17M in FY2025 with a 3-year CAGR of +79.3%.
Improved from -$3M to $17M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +79.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 216 in Health CareTop 26% of 216This company $16.5M Sector average $454.3M
▼
-96.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +79.3%, indicating consistent growth.
- In FY2025, net income increased 59.4% year-over-year.
- Ranks #56 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.5M | +59.4% |
| FY2024 | $10.4M | +425.6% |
| FY2023 | -$3.2M | -211.1% |
| FY2022 | $2.9M | +129.6% |
| FY2021 | -$9.7M | -18.8% |
| FY2020 | -$8.1M | +52.9% |
| FY2019 | -$17.3M | +11.7% |
| FY2018 | -$19.6M | -19.7% |
| FY2017 | -$16.3M | +18.0% |
| FY2016 | -$19.9M | -27.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026